Studying Alzheimer’s disease through an integrative serum metabolomic and lipoproteomic approach
Abstract Background Alzheimer’s disease (AD) is the most frequent neurodegenerative disorder worldwide. The great variability in disease evolution and the incomplete understanding of the molecular mechanisms underlying AD make it difficult to predict when a patient will convert from prodromal stage...
Saved in:
Main Authors: | Alessia Vignoli, Giovanni Bellomo, Federico Paolini Paoletti, Claudio Luchinat, Leonardo Tenori, Lucilla Parnetti |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-01-01
|
Series: | Journal of Translational Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12967-025-06148-4 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Investigating the Therapeutic Mechanisms of Total Saikosaponins in Alzheimer’s Disease: A Metabolomic and Proteomic Approach
by: Huiling Wei, et al.
Published: (2025-01-01) -
Untargeted urine metabolomics reveals dynamic metabolic differences and key biomarkers across different stages of Alzheimer’s disease
by: Xiaoya Feng, et al.
Published: (2025-01-01) -
Investigating the neuroprotective effects of Dracocephalum moldavica extract and its effect on metabolomic profile of rat model of sporadic Alzheimer's disease
by: Marjan Talebi, et al.
Published: (2025-02-01) -
Multi-omics analyses identify gut microbiota-fecal metabolites-brain-cognition pathways in the Alzheimer’s disease continuum
by: Han Zhao, et al.
Published: (2025-02-01) -
Alterations of amino acids in older adults with Alzheimer’s Disease and Vascular Dementia
by: Xin Ma, et al.
Published: (2025-01-01)